CSOWM with questions and well
verified answers actual exam!!!
2026
Management of BMI >/= 25 - ANSWER -Diet, Exercise, Behavior
Management of BMI >/=30 - ANSWER -Diet, exercise, behavior + pharmacotherapy
Management of BMI >/= 27 + comorbidity - ANSWER -Diet, exercise, behavior +
pharmacotherapy
Management of BMI >/=35 + cormorbidity - ANSWER -Bariatric surgery
Management of BMI >/=40 - ANSWER -Bariatric surgery
Co-morbidities - ANSWER -T2DM
HTN
OSA and other respiratory disorders
NAFLD
OA
lipid abnormalities
gastrointestinal disorders
heart disease
,Avoid these wt loss medications with CVD - ANSWER -Sypathomimetics
T2DM treatment + medications to support weight loss - ANSWER -GLP-1 analog
(mitigates associated weight gain due to insulin) or SGLT-2 inhibitors + metformin. If using
insulin, recommend basal instead of combo
Drugs that induce weight gain - ANSWER -Tricyclic antidepressants (Amitriptyline)
oral contraceptives (Ortho Tri-Cyclen, Yaz)
antipsychotics (Risperidone)
anticonvulsants
glucocorticoids (cortisol)
sulfonyureas- ( Glimepiride, Glipizide)
glitazones (Actos)
B-blockers (Propranolol, Metoprolol, Atenolol)
Hormonal signals for appetite - ANSWER -CCK- duodenum
K cells- duodenum and jejunum: gatric inhibitory polypeptide
PYY- ileum and colon
GLP-1 -ileum
Pancreas- Insulin
Adipose tissue: Leptin
Liver- glucagon
GLP-1 - ANSWER -Secreted in response to glucose and promotes insulin release from
pancreas and satiety
Ghrelin - ANSWER -produced in the stomach, orexigenic
Leptin - ANSWER -proportional to fat mass, anorexigenic
, Inhibits appetite
PYY - ANSWER -Ileum and colon, anorexigenic
CCK - ANSWER -duodenum, anorexigenic
Insulin - ANSWER -Pancreas, anorexigenic
Phentermine - ANSWER -noradrenergic, dopaminergic sympathomimetic amine
Start with 7.5-15mg/d, increase only with no results
Do not prescribe for someone with hx of psych dz or substance abuse
Lorcaserin (Belviq) - ANSWER -Seratonin agent, stimulates seratonin type 2 receptor
Brand name: Phentermine/Topiramate - ANSWER -Qysemia
Phentermine/Topiramate (Qysemia) - ANSWER -Phentermine- stimulant
Topiramate- neurostabilizer + antiseizure
Bupropion (Wellbutrin) - ANSWER -Dopamine + norepinepherine reuptake inhibitor
Stimulates POMC neurons
Sibutramine (Meridia) - ANSWER -Discontinued-
Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic
verified answers actual exam!!!
2026
Management of BMI >/= 25 - ANSWER -Diet, Exercise, Behavior
Management of BMI >/=30 - ANSWER -Diet, exercise, behavior + pharmacotherapy
Management of BMI >/= 27 + comorbidity - ANSWER -Diet, exercise, behavior +
pharmacotherapy
Management of BMI >/=35 + cormorbidity - ANSWER -Bariatric surgery
Management of BMI >/=40 - ANSWER -Bariatric surgery
Co-morbidities - ANSWER -T2DM
HTN
OSA and other respiratory disorders
NAFLD
OA
lipid abnormalities
gastrointestinal disorders
heart disease
,Avoid these wt loss medications with CVD - ANSWER -Sypathomimetics
T2DM treatment + medications to support weight loss - ANSWER -GLP-1 analog
(mitigates associated weight gain due to insulin) or SGLT-2 inhibitors + metformin. If using
insulin, recommend basal instead of combo
Drugs that induce weight gain - ANSWER -Tricyclic antidepressants (Amitriptyline)
oral contraceptives (Ortho Tri-Cyclen, Yaz)
antipsychotics (Risperidone)
anticonvulsants
glucocorticoids (cortisol)
sulfonyureas- ( Glimepiride, Glipizide)
glitazones (Actos)
B-blockers (Propranolol, Metoprolol, Atenolol)
Hormonal signals for appetite - ANSWER -CCK- duodenum
K cells- duodenum and jejunum: gatric inhibitory polypeptide
PYY- ileum and colon
GLP-1 -ileum
Pancreas- Insulin
Adipose tissue: Leptin
Liver- glucagon
GLP-1 - ANSWER -Secreted in response to glucose and promotes insulin release from
pancreas and satiety
Ghrelin - ANSWER -produced in the stomach, orexigenic
Leptin - ANSWER -proportional to fat mass, anorexigenic
, Inhibits appetite
PYY - ANSWER -Ileum and colon, anorexigenic
CCK - ANSWER -duodenum, anorexigenic
Insulin - ANSWER -Pancreas, anorexigenic
Phentermine - ANSWER -noradrenergic, dopaminergic sympathomimetic amine
Start with 7.5-15mg/d, increase only with no results
Do not prescribe for someone with hx of psych dz or substance abuse
Lorcaserin (Belviq) - ANSWER -Seratonin agent, stimulates seratonin type 2 receptor
Brand name: Phentermine/Topiramate - ANSWER -Qysemia
Phentermine/Topiramate (Qysemia) - ANSWER -Phentermine- stimulant
Topiramate- neurostabilizer + antiseizure
Bupropion (Wellbutrin) - ANSWER -Dopamine + norepinepherine reuptake inhibitor
Stimulates POMC neurons
Sibutramine (Meridia) - ANSWER -Discontinued-
Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic
